Ribogene, Inc.
11Patents
0Active
11Granted
33Portfolio score
Filing activity: Jul 23, 1993 → Feb 23, 1999
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5738985A | Method for selective inactivation of viral replication | Chemistry; Metallurgy | 107 | Expired |
| USRE36744E | Nasal administration of benzodiazepine hypnotics | General | 64 | Expired |
| US5387613A | Treatment of tachyarrhythmias of supraventricular origin | Human Necessities | 26 | Expired |
| US5641627A | Methods for screening for antimycotics | Chemistry; Metallurgy | 19 | Expired |
| US5874231A | Methods of screening for non-hormone compounds which effect modulation of polypeptide translation | Physics | 15 | Expired |
| US6156496A | Method for selective inactivation of viral replication | Chemistry; Metallurgy | 14 | Expired |
| US5998159A | Methods for screening for antibiotics | Chemistry; Metallurgy | 10 | Expired |
| US5760086A | Nasal administration of agents for treatment of delayed onset emesis | Human Necessities | 9 | Expired |
| US5871923A | Methods for screening for antimycotics | Chemistry; Metallurgy | 8 | Expired |
| US6111077A | Methods for treating hormone disorders | Physics | 2 | Expired |
| US5498636A | Treatment of angina pectoris | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.